Literature DB >> 31699194

[Gut Microbiome Differences between Gastrointestinal Cancer Patients and Healthy People].

Ning Ning Li1, Chun Mei Bai1, Lin Zhao1, Yu Ping Ge1.   

Abstract

Objective To compare the differences in fecal flora among patients with esophageal cancer,gastric cancer,or colorectal cancer and between patients with gastrointestinal tumors and healthy people.Methods The 16S rRNA method was used to analyze the differences in fecal flora among 13 patients with esophageal squamous cell carcinoma,23 patients with gastric cancer,6 patients with colorectal cancer,and 49 healthy persons.Results Bifidobacterium,Faecalibacterium prausnitzii,and Ruminococcus callidus were less abundant in the fecal flora of cancer patients than in those of healthy controls(all P<0.05).Some species of Firmicutes and Actinobacteria were significantly reduced in the feces of patients with esophageal cancer or gastric cancer than in healthy people(P<0.05),whereas others showed consistency with the intestinal cancer group.Anti-tumor treatment,antibiotics,and lactic acid could affect the fecal flora of cancer patients.Conclusion The gut microbiota compositions(mainly Firmicutes and Actinobacteria)and some specific bacteria species in the feces of patients with esophageal cancer and gastric cancer are similar to those in the feces of patients with intestinal cancer,suggesting these bacteria may be involved in the development of upper gastrointestinal tumors.

Entities:  

Keywords:  cancer; gastrointestinal neoplasms; gut microbiome

Mesh:

Substances:

Year:  2019        PMID: 31699194     DOI: 10.3881/j.issn.1000-503X.11372

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  5 in total

Review 1.  Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.

Authors:  Changchang Chen; Linjie Chen; Lijun Lin; Dazhi Jin; Yaoqiang Du; Jianxin Lyu
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-26       Impact factor: 4.813

2.  Comparative analysis of type 2 diabetes-associated gut microbiota between Han and Mongolian people.

Authors:  Shu-Chun Li; Yao Xiao; Ri-Tu Wu; Dan Xie; Huan-Hu Zhao; Gang-Yi Shen; En-Qi Wu
Journal:  J Microbiol       Date:  2021-05-15       Impact factor: 3.422

Review 3.  Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis.

Authors:  Seyedeh Zahra Bakhti; Saeid Latifi-Navid
Journal:  BMC Microbiol       Date:  2021-09-23       Impact factor: 3.605

4.  Bacillus velezensis A2 Inhibited the Cecal Inflammation Induced by Zearalenone by Regulating Intestinal Flora and Short-Chain Fatty Acids.

Authors:  Jing Cai; Nan Wang; Jia Chen; Aibo Wu; Eugenie Nepovimova; Martin Valis; Miao Long; Wenda Wu; Kamil Kuca
Journal:  Front Nutr       Date:  2022-03-03

5.  The Effects of Prebiotic Supplementation with OMNi-LOGiC® FIBRE on Fecal Microbiome, Fecal Volatile Organic Compounds, and Gut Permeability in Murine Neuroblastoma-Induced Tumor-Associated Cachexia.

Authors:  Beate Obermüller; Georg Singer; Bernhard Kienesberger; Ingeborg Klymiuk; Daniela Sperl; Vanessa Stadlbauer; Angela Horvath; Wolfram Miekisch; Peter Gierschner; Reingard Grabherr; Hans-Jürgen Gruber; Maria D Semeraro; Holger Till; Christoph Castellani
Journal:  Nutrients       Date:  2020-07-08       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.